Moving Forward in the Management of Acute GvHD

home / precision-medicine / moving-forward-in-the-management-of-acute-gvhd

Expert physicians discuss the rationale behind the clinical use of JAK inhibitors in acute GvHD (graft-versus-host disease), and provide an overview of recent clinical trial data for this treatment approach.

Janus Kinase Signaling Role in Pathogenesis of GvHD

EP. 1: Janus Kinase Signaling Role in Pathogenesis of GvHD

Targeted Oncology
December 23rd 2020

A discussion on the role on Janus kinase signaling in the pathogenesis of acute and chronic graft-vs-host disease (GVHD).

Watch

JAK Inhibitor Efficacy in Steroid Refractory GVHD

EP. 2: JAK Inhibitor Efficacy in Steroid Refractory GVHD

Targeted Oncology
December 23rd 2020

Expert physicians discuss the role and efficacy of JAK inhibitors in steroid-refractory graft-vs-host disease (GVHD).

Watch

First-Line Steroid Treatment Goals in Acute GVHD

EP. 3: First-Line Steroid Treatment Goals in Acute GVHD

Targeted Oncology
December 23rd 2020

Key opinion leaders discuss treatment goals for frontline therapy in patients with acute graft-vs-host disease.

Watch

Phase III REACH2 Study Overview

EP. 4: Phase III REACH2 Study Overview

Targeted Oncology
December 23rd 2020

A discussion on decision factors for switching to and deciding upon a second-line therapy, and an overview of the phase 3 REACH2 study with ruxolitinib for glucocorticoid-refractory acute graft-vs-host disease (GVHD).

Watch

Practical Advice for Implementing the REACH2 Regimen

EP. 5: Practical Advice for Implementing the REACH2 Regimen

Targeted Oncology
December 23rd 2020

Key opinion leaders provide community oncologists with advice for implementing the REACH2 regimen to manage patients with acute graft-vs-host disease (GVHD).

Watch

The Promising Future of GVHD Management

EP. 6: The Promising Future of GVHD Management

Targeted Oncology
December 23rd 2020

Expert physicians consider how ongoing developments will impact the treatment paradigm of graft-vs-host disease.

Watch

ASH 2020 Clinical Trial Data

EP. 7: ASH 2020 Clinical Trial Data

Targeted Oncology
December 23rd 2020

A discussion on upcoming clinical trial data presentations featured at the American Society of Hematology (ASH) 2020 Annual Meeting.

Watch

Acute GVHD Prophylaxis Protocol

EP. 8: Acute GVHD Prophylaxis Protocol

Targeted Oncology
December 23rd 2020

Key opinion leaders close the discussion by providing insight into their respective protocols for acute graft-vs-host (GVHD) disease prophylaxis.

Watch